ScienceDaily

One CRISPR treatment cut “bad” cholesterol in half for a full year

A single dose of an experimental CRISPR therapy cut LDL cholesterol and triglycerides by about half in patients with difficult-to-treat lipid disorders. The reductions were still present one year later, with the highest dose lowering LDL by 52.5% and triglycerides by 47.8%.

By ScienceDaily

1 min read
One CRISPR treatment cut “bad” cholesterol in half for a full year
One CRISPR treatment cut “bad” cholesterol in half for a full year

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Medical Science

Related Insights